A detailed history of Moneco Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Moneco Advisors, LLC holds 9,731 shares of BMY stock, worth $389,142. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,731
Previous 9,709 0.23%
Holding current value
$389,142
Previous $498,000 5.82%
% of portfolio
0.09%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $1,055 - $1,196
22 Added 0.23%
9,731 $527,000
Q4 2023

Mar 13, 2024

BUY
$48.48 - $57.85 $120,909 - $144,277
2,494 Added 34.57%
9,709 $498,000
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $120,715 - $144,046
2,490 Added 34.59%
9,689 $497,000
Q3 2023

Mar 13, 2024

SELL
$57.89 - $64.73 $22,808 - $25,503
-394 Reduced 5.18%
7,215 $418,000
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $22,866 - $25,568
-395 Reduced 5.2%
7,199 $417,000
Q2 2023

Mar 13, 2024

SELL
$63.71 - $70.74 $132,516 - $147,139
-2,080 Reduced 21.47%
7,609 $486,000
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $24,655 - $27,376
387 Added 5.37%
7,594 $485,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $139,239 - $157,929
2,119 Added 41.65%
7,207 $499,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $410 - $486
6 Added 0.12%
5,088 $366,000
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $30 - $18,134
-236 Reduced 4.44%
5,082 $361,000
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $28,176 - $31,032
388 Added 7.87%
5,318 $409,000
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $6,947 - $8,330
-113 Reduced 2.24%
4,930 $360,000
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $15,230 - $17,755
-284 Reduced 5.33%
5,043 $323,000
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $32,898 - $38,536
-556 Reduced 9.45%
5,327 $315,000
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $15,044 - $16,383
243 Added 4.31%
5,883 $393,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $117,077 - $131,678
1,973 Added 53.8%
5,640 $356,000
Q4 2020

Jan 22, 2021

SELL
$57.74 - $65.43 $5,774 - $6,543
-100 Reduced 2.65%
3,667 $237,000
Q3 2020

Oct 20, 2020

BUY
$57.43 - $63.64 $216,338 - $239,731
3,767 New
3,767 $227,000
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $178,825 - $259,875
-3,854 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $189,655 - $247,388
3,854 New
3,854 $257,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Moneco Advisors, LLC Portfolio

Follow Moneco Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.